- Capital Cube•25 days ago
Click here to see latest analysisCapitalcube gives Meridian Bioscience, Inc. a score of 66.Our analysis is based on comparing Meridian Bioscience, Inc. with the following peers – Quidel Corporation, Alere Inc., Cepheid, ERBA Diagnostics, Inc., Hologic, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Oxford Immunotec Global PLC and BG Medicine, Inc. (QDEL-US, ALR-US, […] (Read more...) The post Meridian Bioscience, Inc. – Value Analysis (NASDAQ:VIVO) : July 1, 2016 appeared first on CapitalCube.
- Capital Cube•26 days agoMeridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : June 30, 2016
Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBullishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day Moving […] (Read more...) The post Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : June 30, 2016 appeared first on CapitalCube.
|Bid||20.35 x 200|
|Ask||20.41 x 200|
|52wk Range||16.60 - 21.49|
|Day's Range||20.18 - 20.41|
|Avg Vol (3m)||218,136|
As of 10:58 AM EDT. NasdaqGS Real Time Price. Market open.